Coloplast (CSE:), a leading medical device company, reported an 8% organic growth and a robust EBIT margin before special items of 27% in Q3 2023. The company’s new intermittent catheter, Luja, equipped with Micro-hole Zone Technology, is expected to set new standards in the market. Despite foreign exchange headwinds impacting…